Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo

Laboratory Investigation

Volumn 76, Issue 4, 1997, Pages 565-577

  Laterra, John ^a,d   Nam, Myeong ^a   Rosen, Eliot ^b   Rao, Jasti S ^c   Lamszus, Katrim ^b   Goldberg, Itzhak D ^b   Johnston, Peter ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; RNA; SCATTER FACTOR; UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GLIOMA; GROWTH REGULATION; HISTOPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REGULATOR GENE;

ANIMALS; BRAIN NEOPLASMS; CELL DIVISION; COLLAGENASES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GLIOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030975492     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, and Oldfield EH (1993). Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153-159.
2. Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, and Zarnegar R (1992). Scatter factor and hepatocyte growth factor: Activities, properties, and mechanism. Cell Growth Diff 3:11-20.
3. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande-Woude GF, and Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804.
4. Bradford MM (1976). A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Cortner J, Vande-Woode GF, and Rong S (1995). The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis. EXS 74:89-121.
6. DiRenzo MF, Narshimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, and Comoglio PM (1991). Expression of the Met/HGF receptor in normal and neoplastic tissues. Oncogene 6:1997-2003.
7. DiRenzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, and Comoglio PM (1994). Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 58:658-662.
8. DiRenzo MF, Poulsom R, Olivero M, Comoglio PM, and Lemoine NR (1995). Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55:1129-1138.
9. Ferracini R, Olivero M, Di-Renzo MF, Martano M, DeGiovanni C, Nanni P, Basso G, Scotlandi K, Lollini PL, and Comoglio PM (1996). Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12:1697-1705.
10. Forough R, Zhan X, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, and Maciag T (1993). Differential transforming abilities of nonsecreted and secreted forms of human fibroblast growth factor-1. J Biol Chem 268:2960-2968.
11. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, and Rosen EM (1993). Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941.
12. Guerin C, Laterra J, Drewes LR, Brem H, and Goldstein GW (1992). Vascular expression of glucose transporter in experimental brain neoplasms. Am J Pathol 140:417-425.
13. Gunther B (1975). On theories of biological similarity. Fortschr Exp Theor Biophys 19:9-28.
14. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, and Nister M (1992). Plateletderived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219.
15. Hsu DW, Efird JT, and Hedleywhyte ET (1995). Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147:114-123.
16. Hsu SM, Raine L, and Fanger H (1981). The use of avidinbiotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
17. Jeffers M, Rong S, and Vande-Woude GF (1996). Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16:1115-1125.
18. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaughnessy P, Goldberg ID, and Rosen EM (1995). Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 87:372-377.
19. Lal B, Indurti RR, Couraud P, Goldstein GW, and Laterra J (1994). Endothelial cell implantation and survival within experimental gliomas. Proc Natl Acad Sci USA 91:9695-9699.
20. Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, and Rosen EM (1997). DNA-mediated transfer of scatter factor to human breast carcinoma cells induces increased tumor growth in mammary fat pads of nude mice. Lab Invest 76:339-353.
21. Leone A, Flatow U, VanHoutte K, and Steeg PS (1993). Transfection of human mn23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8:2325-2333.
22. Maxwell M, Naber SP, Wolfe HJ, Hedleywhyte ET, Galanopoulos T, Nevillegolden J, and Antoniades HN (1991). Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51:1345-1351.
23. Millauer B, Shawver LK, Plate KH, Risau W, and Ullrich A (1994). Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature 367:576-579.
24. Moriyama T, Kataoka H, Tsubouchi H, and Koono M (1995). Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372:78-82.
25. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440-443.
26. Nam M, Johnston P, Lal B, Indurti R, Wilson MA, and Laterra J (1996). Endothelial cell-based anti-tumor gene delivery to brain. Brain Res 731:161-170.
27. Plate KH, Breier G, Farrel CL, and Risau W (1992). Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67:529-534.
28. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, and Comoglio PM (1991). The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49:323-328.
29. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, and Sawaya R. (1993a). Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 53:2208-2211.
30. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA, and Sawaya R. (1993b). Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol 18:129-138.
31. Rifkin DB, Gross JL, Moscatelli D, and Gabrielides C (1981). The involvement of proteases and protease inhibitors in neovascularization. Acta Biol Med Ger 40:1259-1263.
32. Rong S, Segal S, Anver M, Resau JH, and Vande-Woude GF (1994). Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91:4731-4735.
33. Rosen EM and Goldberg ID (1995). Scatter factor and angiogenesis. Adv Cancer Res 67:257-279.
34. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, Mcclellan J, Kluger MJ, Goldberg ID, and Zitnik R (1994a). Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127:225-234.
35. Rosen EM, Knesel J, Goldberg ID, Jin L, Bhargava M, Joseph A, Zitnik R, Wines J, Kelley M, and Rockwell S. (1994b). Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 57:706-714.
36. Rosen EM, Laterra J, Joseph A, Jin L, Way D, Witte M, Weinarnd M, and Goldberg I (1996). Scatter factor expression and regulation in human glial tumors. Int J Cancer 67:1-8.
37. Schmidek H, Nielsen S, Schiller A, and Messer J (1971). Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg 34:335-340.
38. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
39. Stoker M, Gherardi E, Perryman M, and Gray J (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:238-242.
40. Tamargo R, Leong K, and Brem H (1990). Growth Inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J Neurooncol 9:131-138.
41. Weidner KM, Behrens J, Vandekerckhove J, and Birchmeier W (1990). Scatter factor: Molecular characteristics and effect on invasiveness of epithelial cells. J Cell Biol 111:2097-2108.
42. Weidner KM, Hartmann G, Sachs M, and Birchmeier W (1993). Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am J Respir Cell Mol Biol 8:229-237.
43. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
44. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL, and Rao JS (1994). Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54:5016-5020.
45. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, and Shin S (1994). Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54:1630-1633.
46. Yang YM, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, and Birchmeier W (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131:215-226.